BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 8793842)

  • 1. A novel cytopathic microtitre plate assay for hepatitis A virus and anti-hepatitis A neutralizing antibodies.
    Beales LP; Wood DJ; Minor PD; Saldanha JA
    J Virol Methods; 1996 May; 59(1-2):147-54. PubMed ID: 8793842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytopathology, plaque assay, and heat inactivation of hepatitis A virus strain HM175.
    Anderson DA
    J Med Virol; 1987 May; 22(1):35-44. PubMed ID: 3035078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a plaque assay for a cytopathic, rapidly replicating isolate of hepatitis A virus.
    Cromeans T; Sobsey MD; Fields HA
    J Med Virol; 1987 May; 22(1):45-56. PubMed ID: 3035079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of the inactivation kinetics of hepatitis A virus in human plasma products using a simple TCID50 assay.
    Barrett PN; Meyer H; Wachtel I; Eibl J; Dorner F
    J Med Virol; 1996 May; 49(1):1-6. PubMed ID: 8732864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A simple antigen-reduction assay for the measurement of neutralizing antibodies to hepatitis A virus.
    Krah DL; Amin RD; Nalin DR; Provost PJ
    J Infect Dis; 1991 Mar; 163(3):634-7. PubMed ID: 1847404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single-antibody in situ enzyme immunoassay for infectivity titration of hepatitis A virus.
    Borovec S; Uren E
    J Virol Methods; 1997 Oct; 68(1):81-7. PubMed ID: 9395142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolation and immunizations with hepatitis A viral structural proteins: induction of antiprotein, antiviral, and neutralizing responses.
    Hughes JV; Stanton LW
    J Virol; 1985 Aug; 55(2):395-401. PubMed ID: 2991564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A simplified multiwell plate assay for the measurement of hepatitis A virus infectivity.
    Krah DL
    Biologicals; 1991 Jul; 19(3):223-7. PubMed ID: 1659431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Laboratory tests and reference reagents employed in studies of inactivated hepatitis A vaccine.
    Binn LN; MacArthy PO; Marchwicki RH; Sjogren MH; Hoke CH; Burge JR; D'Hondt E
    Vaccine; 1992; 10 Suppl 1():S102-5. PubMed ID: 1335636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Preparation and characteristics of cultured strains of hepatitis A virus from humans and monkeys].
    Korzaia LI; Shevtsova ZV; Lapin BA; D'iachenko AG; Krylova RI
    Vopr Virusol; 1997; 42(2):60-3. PubMed ID: 9182400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Indigenous anti-hepatitis A virus IgM capture ELISA for the diagnosis of hepatitis A.
    Chitambar SD; Murthy-Grewal S; Bokil M; Arankalle VA; Gore MM; Banerjee K
    Indian J Med Res; 1994 Jun; 99():243-51. PubMed ID: 8088883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunologic approaches to assessing the response to inactivated hepatitis A vaccine.
    Lemon SM
    J Hepatol; 1993; 18 Suppl 2():S15-9. PubMed ID: 8182266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infectivity titration of the fast-replicating and cytopathic hepatitis A virus strain HM175A.2 by an in situ enzyme immunoassay.
    Yap KL; Lam SK
    J Virol Methods; 1994 Apr; 47(1-2):217-26. PubMed ID: 8051228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incomplete neutralization of hepatitis A virus in vitro due to lipid-associated virions.
    Lemon SM; Binn LN
    J Gen Virol; 1985 Nov; 66 ( Pt 11)():2501-5. PubMed ID: 2997380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunochemiluminescent focus assays for the quantitation of hepatitis A virus and rotavirus in cell cultures.
    Richards GP; Watson MA
    J Virol Methods; 2001 May; 94(1-2):69-80. PubMed ID: 11337041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The isolation and study of the characteristics of a cytopathic strain of the hepatitis A virus].
    Maĭdaniuk AG; Tiunnikov GI; Konakova VE; Bondarenko EP; Nemtsov IuV; Karpovich LG; Kalashnikova TV; Mamaeva NV; Sosnovtsev SV; Chizhikov VE
    Vopr Virusol; 1993; 38(3):101-5. PubMed ID: 8073747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antigenicity of hepatitis A virus after ultra-violet inactivation.
    Wang CH; Tschen SY; Flehmig B
    Vaccine; 1995 Jun; 13(9):835-40. PubMed ID: 7483806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunogenicity of a hepatitis A virus vaccine.
    Flehmig B; Haage A; Pfisterer M
    J Med Virol; 1987 May; 22(1):7-16. PubMed ID: 3035082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Study of human and simian hepatitis A virus isolated by an immunoenzyme method using polyclonal and monoclonal antibodies].
    Karetnyĭ IuV; Andzhaparidze AG; Orlova TM; Balaian MS
    Vopr Virusol; 1989; 34(1):50-3. PubMed ID: 2543140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A simple method for clonal selection of hepatitis A virus based on recovery of virus from radioimmunofocus overlays.
    Lemon SM; Jansen RW
    J Virol Methods; 1985 Jun; 11(2):171-6. PubMed ID: 2991315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.